Third Rock launches Sage Therapeutics with $35m in Series A financing
Link submited on October 18, 2011 12:19 by Maurine Belinda Belamide
Author: Chris Reidy
Source: Boston.com
Interest: Third Rock Ventures LLC, a Boston venture capital firm, announced the formation of Sage Therapeutics, a company that looks to develop new treatments for central nervous system disorders such as schizophrenia, depression, pain, and traumatic brain injury.
Link: http://www.boston.com/Boston/businessupdates/2011/10/third-rock-ventures-launches-sage-therapeutics-with-series-financing/vobuOYoEzG1t1wbkaE7BkL/index.html
Tags: SBIR,General,Announcements,Research Commercialization,Venture Capital,NanoTech,Universities